Published in Oncogene on August 25, 2014
Targeting prion protein interactions in cancer. Prion (2015) 0.81
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells. Oncotarget (2016) 0.77
The Cellular Prion Protein: A Player in Immunological Quiescence. Front Immunol (2015) 0.76
PRNP/prion protein regulates the secretion of exosomes modulating CAV1/caveolin-1-suppressed autophagy. Autophagy (2016) 0.76
Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells. Clin Exp Metastasis (2016) 0.76
Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts. Cancers (Basel) (2016) 0.75
Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Stem Cell Res Ther (2017) 0.75
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
A restricted cell population propagates glioblastoma growth after chemotherapy. Nature (2012) 8.88
The definition of primary and secondary glioblastoma. Clin Cancer Res (2012) 3.84
Physiology of the prion protein. Physiol Rev (2008) 2.65
An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg (2000) 2.50
NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics (2009) 2.34
The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci (2011) 1.66
Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J (2002) 1.58
Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics (2007) 1.57
Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci (2005) 1.54
Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep (2013) 1.44
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene (2012) 1.35
Extracellular roles for the molecular chaperone, hsp90. Cell Cycle (2004) 1.35
MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33
Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One (2011) 1.25
Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J (2006) 1.23
RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. Cancer Lett (2011) 1.13
Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol (2009) 1.12
Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem (2007) 1.09
Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics (2010) 1.06
Dynamics of the regulation of Hsp90 by the co-chaperone Sti1. EMBO J (2012) 1.05
STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia (2007) 1.02
Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest (2009) 1.02
Short-term memory formation and long-term memory consolidation are enhanced by cellular prion association to stress-inducible protein 1. Neurobiol Dis (2007) 1.02
POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Res (2008) 1.01
Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. J Transl Med (2011) 0.97
Enhanced neural progenitor/stem cells self-renewal via the interaction of stress-inducible protein 1 with the prion protein. Stem Cells (2011) 0.97
Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells. Cell Rep (2012) 0.97
A compound that inhibits the HOP-Hsp90 complex formation and has unique killing effects in breast cancer cell lines. Mol Pharm (2011) 0.95
Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis. J Biol Chem (2010) 0.95
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells. Autophagy (2011) 0.95
Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones (2010) 0.94
Drug delivery strategies for the treatment of malignant gliomas. Int J Pharm (2012) 0.94
Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials. Neuroimaging Clin N Am (2010) 0.93
Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci (2009) 0.93
Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol (2008) 0.92
Standard of care therapy for malignant glioma and its effect on tumor and stromal cells. Oncogene (2011) 0.92
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Ann Oncol (2007) 0.91
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer. Cell Mol Biol Lett (2012) 0.91
Cellular prion protein promotes glucose uptake through the Fyn-HIF-2α-Glut1 pathway to support colorectal cancer cell survival. Cancer Sci (2011) 0.88
A comparison between manual and automated evaluations of tissue microarray patterns of protein expression. J Histochem Cytochem (2013) 0.88
Endpoints for clinical trials and revised assessment in neuro-oncology. Curr Opin Neurol (2012) 0.86
Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer. Mol Carcinog (2010) 0.84
Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells. Mol Cancer (2012) 0.83
Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review. Expert Rev Anticancer Ther (2012) 0.82
TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. Int J Cancer (2011) 0.81
Knockdown of Hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines. Cancer Lett (2012) 0.81
The unconventional secretion of stress-inducible protein 1 by a heterogeneous population of extracellular vesicles. Cell Mol Life Sci (2013) 0.81
Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repository. Cancer Biomark (2012) 0.81
Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli. PLoS One (2012) 0.79
The growth of glioblastoma orthotopic xenografts in nude mice is directly correlated with impaired object recognition memory. Physiol Behav (2013) 0.78
¹H, ¹⁵N and ¹³C backbone resonance assignments of the TPR1 and TPR2A domains of mouse STI1. Biomol NMR Assign (2012) 0.76